Community health management combined with tertiary care significantly improves dry eye disease cognition, symptoms, psychological state, and quality of life.
The phase 3 DRAGON study met its primary endpoint, demonstrating tinlarebant’s efficacy in slowing retinal degeneration in Stargardt disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback